Exabeam IPO: Revenue, Investors, Valuation & How to Invest

What is Exabeam?

Exabeam is a cybersecurity firm that uses behavioural analytics, security automation, and security log management to help companies detect, analyse, and create a response to security threats. The term for this is ‘SIEM’, which stands for ‘security information and event management.’

The company started in 2013 after founder Nir Polak had his credit details stolen. This led him to wonder why cybersecurity firms weren’t using technology similar to credit card companies that could spot employee behaviours and signal a potential insider threat. Other companies have attempted to solve this problem but used ‘expert’ knowledge instead of systems based on AI and machine learning. So, Exabeam carved out its own place within cybersecurity under the category of UEBA (user and entity behaviour analytics).

Exabeam set out to combine the use of AI, big data, and cloud infrastructure capabilities to better protect clients. If you’re wondering where the name comes from, ‘exa’ refers to an exabyte (a billion gigabytes) and the ‘beam’ is due to the team’s beliefs that ‘the product also acted like a beam of light, shining down on interesting patterns contained in huge volumes of log data.’. Somewhat corny, but the end result sounds pretty good.

Exabeam key company facts

Exabeam company statistics

Below is a breakdown of some key information, including Exabeam’s products, top investors, and competitors.

Exabeam products

Following the July 2024 merger with LogRhythm, Exabeam now offers a unified portfolio organized around two main platforms – the cloud-native New-Scale Platform and the self-hosted LogRhythm SIEM Platform – both powered by Exabeam Nova AI agents. The current product line-up looks like this:

1. New-Scale Security Operations Platform (cloud-native SIEM, log management, and TDIR)
2. New-Scale Fusion (combines New-Scale SIEM with behavioral analytics in a single platform)
3. New-Scale Security Analytics (behavioral baselining, dynamic risk scoring, and Agent Behavior Analytics)
4. LogRhythm SIEM (on-premises / self-hosted SIEM, updated quarterly)
5. LogRhythm Intelligence (adds ML-driven behavioral analytics to LogRhythm SIEM as an add-on)
6. Exabeam Nova (generative AI agents for threat triage, investigation, and response)
7. NetMon (network traffic monitoring and analysis)

Exabeam’s competitors

The cybersecurity sector is constantly evolving, with the SIEM and security operations space in particular reshaping around AI-driven detection, cloud-native architectures, and platform consolidation. Here are some of Exabeam’s main competitors at the moment:

• Splunk (now part of Cisco)
• Microsoft Sentinel
• CrowdStrike (Falcon Next-Gen SIEM)
• Palo Alto Networks (Cortex XSIAM)
• Google Security Operations (Chronicle)
• IBM QRadar
• Securonix
• Rapid7
• Sumo Logic
• Elastic Security
• SentinelOne (Singularity AI SIEM)
• Gurucul
• Devo
• Logpoint

Exabeam’s top investors

Since the July 2024 merger with LogRhythm, Exabeam is majority-owned by private equity firm Thoma Bravo, with the company’s earlier venture capital backers retaining minority stakes. Key investors in Exabeam include:

• Thoma Bravo (majority owner, via LogRhythm)
• Blue Owl Capital (formerly Owl Rock)
• Lightspeed Venture Partners
• Norwest Venture Partners
• Acrew Capital
• Cisco Investments
• Sapphire Ventures
• Aspect Ventures
• Icon Ventures
• Next Play Capital

When is the Exabeam IPO?

There’s no confirmed date for an Exabeam IPO. Earlier reports from 2019-2020 suggested the company was eyeing a public listing, but those plans were repeatedly pushed back. The most significant development since then was the July 2024 merger with Thoma Bravo-owned LogRhythm, which combined the two SIEM vendors under the Exabeam name and made Thoma Bravo the majority owner of the company.

This ownership structure changes the IPO calculus meaningfully. Thoma Bravo is a private equity firm that typically exits portfolio companies either through an IPO or through a strategic sale, and with the broader IPO market reopening in 2025-2026 after the post-pandemic freeze, a public listing has become more plausible than it was a couple of years ago. Cybersecurity peers such as Rubrik (2024) have already returned to the public markets, and Crunchbase and EY both point to cybersecurity as one of the more active IPO segments going into 2026.

That said, there are still several reasons why an Exabeam IPO is not a near-term certainty. The company is still digesting the LogRhythm merger and a recent leadership transition, with Pete Harteveld taking over as CEO in October 2025. Thoma Bravo could also opt for a strategic sale instead of a public listing, which is common in cybersecurity consolidation (Cisco/Splunk and Palo Alto/QRadar being recent examples). And while macro conditions have improved, valuation compression in the SIEM space and competitive pressure from platform players like CrowdStrike, Microsoft, and Palo Alto Networks could push Thoma Bravo to wait for stronger comparables before testing the public market.

For investors interested in the cybersecurity sector, Exabeam remains a name to watch, but with the caveat that a 2026 IPO has not been announced and any timeline depends primarily on Thoma Bravo’s exit strategy and broader market conditions.

How to invest and buy shares after the Exabeam IPO

After the Exabeam IPO date, you can freely buy the newly listed stock. Interactive Brokers and eToro are two top-rated brokers where you can access Exabeam shares and buy the stock with low fees after the IPO. Take a look at both these brokerage options below:

Founded in 1978, the IBKR platform lets you access over 150 market destinations in 33 countries and trade any asset you may be looking for: Stocks, Bonds, ETFs, Forex, Funds, Commodities, Options, Futures, CFDs, Cryptos Futures, and even tiny small companies (a.k.a micro caps).

If you want to buy Exabeam stock after the IPO, here’s how you can buy shares using Interactive Brokers:

1. Open a trading account with Interactive Brokers.
2. Deposit funds into your account.
3. Once it’s available, search for the Exabeam stock; there is no confirmed ticker symbol right now.
4. Place the type of order you wish to use (e.g. market, limit, stop etc.).
5. Once you’ve bought your desired number of Exabeam shares, continue to monitor performance.

If you’d like to learn more about the IBKR platform, check out our full-length Interactive Brokers review.

Founded in 2006 in Israel, eToro now has over 30 million customers worldwide. The platform is widely known for its social and copy-trading features. It allows users to trade stocks, forex, commodities, cryptocurrencies, CFDs, and ETFs.

If you’re planning to buy Exabeam stock after the IPO, here’s how you can buy shares using eToro:

1. Open an account with eToro.
2. Head to the ‘Markets’ page and select ‘Stocks.’
3. Search for the Exabeam stock and select ‘Trade’.
4. Next, hit ‘BUY.’
5. Choose how much you want to invest in Exabeam or the number of shares you want to buy.
6. Select your leverage (or ensure that leverage is set to X1).
7. Decide on a take-profit parameter if you want to automate a future sale of your Exabeam stock.
8. Finally, hit ‘Open Trade’.

If you’d like to learn more about eToro, check out our in-depth eToro review.

Bottom line on investing in the Exabeam IPO

An eventual Exabeam IPO would offer investors exposure to one of the larger players in the security information and event management (SIEM) and user and entity behaviour analytics (UEBA) space. Following the July 2024 merger with LogRhythm, Exabeam combines two well-established SIEM franchises and has been named a Leader in the Gartner Magic Quadrant for SIEM six times under the Exabeam name (and 15 times in total when including LogRhythm’s pre-merger placements).

The main argument in favour is that the combined company has meaningful scale, a large installed base of enterprise customers, and a clear AI-driven product roadmap built around the New-Scale Platform and Exabeam Nova agents. With Thoma Bravo as majority owner and the IPO market reopening in 2025-2026, a public listing has become a plausible exit path, alongside the alternative of a strategic sale to a larger platform vendor.

The main risks are competitive and structural. The SIEM market is consolidating around larger platform players such as CrowdStrike, Microsoft, Palo Alto Networks, and Cisco-owned Splunk, all of which have deeper pockets and broader product portfolios. Some analysts have noted that Exabeam and Securonix are losing differentiation in the Leaders quadrant, which could pressure growth and valuation if the trend continues. There’s also integration risk from the LogRhythm merger and a recent CEO transition, with Pete Harteveld taking over in October 2025.

The bottom line: there is no confirmed Exabeam IPO date, and any listing depends primarily on Thoma Bravo’s exit strategy and broader market conditions. For investors interested in the cybersecurity sector, Exabeam is worth tracking, but it should be weighed against already-public SIEM and security operations peers such as CrowdStrike, Palo Alto Networks, SentinelOne, and Rapid7, all of which offer immediate exposure to the same long-term trends without the uncertainty of waiting for a private-to-public transition.